$3.07
-0.01 (-0.32%)
Open$3.08
Previous Close$3.08
Day High$3.11
Day Low$3.01
52W High$9.99
52W Low$1.98
Volume—
Avg Volume34.1K
Market Cap26.44M
P/E Ratio—
EPS$-0.87
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,340.7% upside
Current
$3.07
$3.07
Target
$44.23
$44.23
$32.29
$44.23 avg
$55.91
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.90M | 15.57M | 15.33M |
| Net Income | 2.99M | 2.88M | 3.11M |
| Profit Margin | 17.7% | 18.5% | 20.3% |
| EBITDA | 3.97M | 4.34M | 3.61M |
| Free Cash Flow | 3.54M | 3.27M | 3.55M |
| Rev Growth | +19.1% | +9.8% | -6.9% |
| Debt/Equity | 0.36 | 0.34 | 0.37 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |